Login / Signup

Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study.

Isabella VisuriCarl ErikssonSara KarlqvistByron LykiardopoulosPer KarlénOlof GripCharlotte SödermanSven AlmerErik HertervigJan MarsalCarolina MalmgrenJenny DelinHans StridMats SjöbergDaniel BergemalmHenrik HjortswangJonas Halfvarson
Published in: Therapeutic advances in gastroenterology (2023)
ENCePP registration number: EUPAS22735.
Keyphrases
  • clinical trial
  • randomized controlled trial
  • study protocol
  • ulcerative colitis
  • patients with inflammatory bowel disease
  • double blind